Sphera Funds Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Sphera Funds Management’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,152,998	Closed	-$5.33M	–	135
2020 Q3	$5.33M	Sell	1,152,998 -1,705,000	-60%	-$5.63M	0.52%	56
2020 Q2	$8.06M	Sell	2,857,998 -73,020	-2%	-$234K	0.76%	35
2020 Q1	$7.15M	Buy	2,931,018 +2,532,477	+635%	+$9.14M	0.89%	26
2019 Q4	$2.04M	Sell	398,541 -270,000	-40%	-$1.5M	0.17%	76
2019 Q3	$4.32M	Hold	668,541	–	–	0.67%	46
2019 Q2	$4.17M	Buy	668,541 +29,999	+5%	+$228K	0.57%	55
2019 Q1	$6.79M	Sell	638,542 -386,458	-38%	-$3.85M	0.62%	36
2018 Q4	$8.17M	Buy	+1,025,000	New	+$14.8M	0.92%	27
2017 Q1	–	Sell	-12,500	Closed	-$1.24M	–	128
2016 Q4	$1.24M	Buy	+12,500	New	+$1.32M	0.31%	78

Other funds holding SIOX

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCA

Sassicaia Capital Advisers Jericho, New York $227M AUM 402.2% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

Sphera Funds Management's SIOX Position: Q4 2020 in Review

Sphera Funds Management sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q4 2020, closing a stake of 1,152,998 shares — an estimated $5.33M sold.

Sphera Funds Management first reported a position in SIOX in Q4 2016 and held it in 9 quarters. The position peaked at $8.17M in Q4 2018. 62 funds tracked by Wall St. Rank hold SIOX as of Q4 2020.

Sphera Funds Management reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Sphera Funds Management sold 1,152,998 Sio Gene Therapies Inc. Common Stock shares in Q4 2020, an estimated $5.33M.
Sphera Funds Management first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2016 and held it in 9 quarters.
Sphera Funds Management's Sio Gene Therapies Inc. Common Stock position peaked at $8.17M in Q4 2018.
62 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2020.

Based on Sphera Funds Management's 13F filing for Q4 2020, filed 16 Feb 2021.